Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €0.15 EUR
Change Today -0.01 / -6.25%
Volume 1.5M
BTH1V On Other Exchanges
Symbol
Exchange
Helsinki
Berlin
OTC US
As of 11:29 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ian John Massey DPhil

Former Chief Operating Officer and Member of the Management Team, Biotie Therapies Corp.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 4 different industries.

See Board Relationships
63--

Background*

Dr. Ian John Massey, D. Phil, has been the President and Chief Operating Officer of StemCells Inc. since March 23, 2015. Dr. Massey Founded of Biotie Therapies AG, and served as its Chief Executive Officer and President since 2006. He served as the Chief Operating Officer at Biotie Therapies Corp. until August 2013 and also served as its President of US Operations. He served as a Member of the Management Team of Biotie Therapies Corp. since February 2011. He is a Senior ...

Read Full Background

Corporate Headquarters*

Joukahaisenkatu 6
Turku, Finland Proper 20520

Finland

Phone: 358 2274 8900
Fax: 358 2274 8910

Board Members Memberships*

Executive Director
2006-2012
Former Director, Chairman of Scientific Review Committee and Member of Executive Compensation Committee

Education*

MA
University of Oxford
PhD
University of Oxford
BA
University of Oxford

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTH1V:FH €0.15 EUR -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$599.8K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$437.4K
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
$467.3K
Mike Tomas Chief Executive Officer, President, Chief Financial Officer, Director and Member of Advisory Board
Bioheart, Inc.
$766.7K
Mark R. Weinreb M.S.Chairman, Chief Executive Officer and President
BioRestorative Therapies, Inc.
$360.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTIE THERAPIES OYJ, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.